Ruxolitinib + capecitabine in advanced/metastatic...

  • Main
  • 2018 / 3
  • Ruxolitinib + capecitabine in advanced/metastatic...

Ruxolitinib + capecitabine in advanced/metastatic pancreatic cancer after disease progression/intolerance to first-line therapy: JANUS 1 and 2 randomized phase III studies

Hurwitz, Herbert, Van Cutsem, Eric, Bendell, Johanna, Hidalgo, Manuel, Li, Chung-Pin, Salvo, Marcelo Garrido, Macarulla, Teresa, Sahai, Vaibhav, Sama, Ashwin, Greeno, Edward, Yu, Kenneth H., Verslype,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Investigational New Drugs
DOI:
10.1007/s10637-018-0580-2
Date:
March, 2018
File:
PDF, 621 KB
english, 2018
Conversion to is in progress
Conversion to is failed